Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Theranos Lab Threatened With CMS Ban, But The Firm Says Corrections Have Been Made

This article was originally published in The Gray Sheet

Executive Summary

Deficiencies that have gone uncorrected by closely watched lab firm Theranos prompted a proposed sanctions letter from CMS last month that threatens barring one of the firm's two laboratories from operating. But Theranos has recently attested that it is cooperating with CMS and that it has since adopted significant quality upgrades in response to the agency's observations.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register